Ascenta Capital
Series A → Series B
Their stated focus (public profile)
Ascenta Capital invests in biotech companies translating scientific foundations into clinical-stage medicines, focusing on Phase 1 and Phase 2 development candidates and multi-medicine platforms. The firm makes concentrated investments of $15–30 million and works collaboratively with management teams, providing strategic and operational support. Its mission is patient-centered, targeting innovations addressing major unmet medical needs.
Stages: Series A → Series B
Sectors: Life sciences, Healthtech
Check size: $15-30 Million
Website: ascentacap.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.